Position in DNLI
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$6,957,260
+$1,700,300 QoQ
Shares Held
270,500
-1.2% QoQ
Ownership
0.169%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 290 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Swiss National Bank holds $1,788,615,626 across 151 Biotechnology names. DNLI ranks #43 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
717,440 | $356,373,971 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
293,020 | $182,709,690 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
374,080 | $112,609,302 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
456,331 | $85,461,669 | |
| 5 | RPRX |
Royalty Pharma plc
|
1,159,800 | $65,029,986 | |
| 6 | INSM |
INSMED Inc
|
593,512 | $63,280,249 | |
| 7 | INCY |
Incyte Corp
|
476,874 | $54,058,436 | |
| 8 | MRNA |
Moderna, Inc.
|
679,900 | $47,613,397 |
All Filings in DNLI
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,957,260 | 270,500 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $5,256,960 | 273,800 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $4,520,438 | 273,800 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $3,884,100 | 267,500 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,510,091 | 250,900 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,410,985 | 250,900 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $5,166,330 | 253,500 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $7,302,891 | 250,700 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $5,405,616 | 232,800 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $4,477,464 | 218,200 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $4,650,382 | 216,700 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $4,967,704 | 240,800 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $7,026,331 | 238,100 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $4,727,808 | 205,200 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $5,798,385 | 208,500 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $6,263,829 | 204,100 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $5,927,202 | 201,400 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $6,038,309 | 187,700 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $7,747,020 | 173,700 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $8,783,345 | 174,100 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $13,475,992 | 171,800 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $10,169,510 | 178,100 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $14,641,248 | 174,800 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $6,435,068 | 179,600 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $4,267,770 | 176,500 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $2,120,461 | 121,100 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||